Amarantus Bioscience Holdings, Inc.

EDGAR

Market value is not computed: no recent price is available.

51 filing records in this dataset, filed from 2008-04-07 to 2016-06-01. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Latest quarter

Revenue

0 USD

2012 Q3 · USD

Exact inputs and evidence

Operating cash flow

390 thousand USD

2012 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: 390245 USD Source
Cash and cash equivalents
100 thousand USD Source
Exact value

100000 USD

Long-term debt including current maturities
Not available
Shares outstanding
57.6 million shares Source
Exact value

57640958 shares

Reported share-count change

-94.30% · -954 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 1012107678 shares · 2015-03-31· Source
  • 57640958 shares · 2016-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-25.9 million USD

2015-04-01 – 2016-03-31

Exact inputs and evidence
  • Net income: -5721000 USD · 2015-04-01 – 2015-06-30 Source
  • Net income: -5722000 USD · 2015-07-01 – 2015-09-30 Source
  • Net income: -25214000 USD · 2015-01-01 – 2015-12-31 Source
  • Net income: -12302000 USD · 2015-01-01 – 2015-09-30 Source
  • Net income: -1576000 USD · 2016-01-01 – 2016-03-31 Source

Operating cash flow

-10.7 million USD

2015-04-01 – 2016-03-31

Exact inputs and evidence
  • Operating cash flow: -12815000 USD · 2015-01-01 – 2015-06-30 Source
  • Operating cash flow: -7805000 USD · 2015-01-01 – 2015-03-31 Source
  • Operating cash flow: -14075000 USD · 2015-01-01 – 2015-09-30 Source
  • Operating cash flow: -12815000 USD · 2015-01-01 – 2015-06-30 Source
  • Operating cash flow: -16014000 USD · 2015-01-01 – 2015-12-31 Source
  • Operating cash flow: -14075000 USD · 2015-01-01 – 2015-09-30 Source
  • Operating cash flow: -2487000 USD · 2016-01-01 – 2016-03-31 Source

Capital expenditure

48 thousand USD

2014-10-01 – 2015-09-30

Exact inputs and evidence
  • Capital expenditure: 181000 USD · 2014-01-01 – 2014-12-31 Source
  • Capital expenditure: 144000 USD · 2014-01-01 – 2014-09-30 Source
  • Capital expenditure: 1000 USD · 2015-01-01 – 2015-03-31 Source
  • Capital expenditure: 5000 USD · 2015-01-01 – 2015-06-30 Source
  • Capital expenditure: 1000 USD · 2015-01-01 – 2015-03-31 Source
  • Capital expenditure: 11000 USD · 2015-01-01 – 2015-09-30 Source
  • Capital expenditure: 5000 USD · 2015-01-01 – 2015-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2016-06-01.

Financial data available through: 2015-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2012-12-31
  • Operating income: 6 of 11 periods available· newest 2015-12-31
  • Net income: 8 of 11 periods available· newest 2015-12-31
  • Operating cash flow: 6 of 11 periods available· newest 2015-12-31
  • Capital expenditure: 6 of 11 periods available· newest 2015-12-31
  • Total assets: 6 of 11 periods available· newest 2015-12-31
  • Total liabilities: 6 of 11 periods available· newest 2015-12-31
  • Current assets: 6 of 11 periods available· newest 2015-12-31
  • Current liabilities: 6 of 11 periods available· newest 2015-12-31
  • Cash and cash equivalents: 7 of 11 periods available· newest 2015-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 4 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +USD 2.06 million

    Prior period

    −USD 27.28 million

    –

    Current period

    −USD 25.21 million

    –

    Exact inputs and evidence

    -25214000 − -27277000 = 2063000 USD

    -27277000 USD · 2014-01-01 – 2014-12-31

    Inspect prior input Prior source

    -25214000 USD · 2015-01-01 – 2015-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 4.68 million

    Prior period

    −USD 11.33 million

    –

    Current period

    −USD 16.01 million

    –

    Exact inputs and evidence

    -16014000 − -11331000 = -4683000 USD

    -11331000 USD · 2014-01-01 – 2014-12-31

    Inspect prior input Prior source

    -16014000 USD · 2015-01-01 – 2015-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -94.5%

    Prior period

    USD 181,000

    –

    Current period

    USD 10,000

    –

    Exact inputs and evidence

    10000 − 181000 = -171000 USD

    181000 USD · 2014-01-01 – 2014-12-31

    Inspect prior input Prior source

    10000 USD · 2015-01-01 – 2015-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2012-01-01 – 2012-12-31

  • Revenue USD 0
  • Operating costs Derived USD 4.09 million
  • Operating income −USD 4.09 million
  • Tax, interest and other Derived USD 1.05 million
  • Net income −USD 5.14 million

Cash

  • Operating cash flow −USD 1.15 million
  • Capital expenditure USD 0
  • Free cash flow Derived −USD 1.15 million

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2011 Operating loss: operating costs were 2,086% of revenue.
  • 2012 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2011 2011-01-01 – 2011-12-31223588 4663691 Derived -4440103 0 Derived -4440103 Unavailable
Source
2012 2012-01-01 – 2012-12-310 4090342 Derived -4090342 1045276 Derived -5135618 -1154126 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2012
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.241.5K181.1K120.7K60.4K0.020112012
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2011Revenue223588
2012Revenue0

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2012
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.8%-21%-50%-79%-108%20112012
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2011Year over yearNo prior comparable period
2012Year over year-100%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,985.8% 2011
Net margin -1,985.8% 2011
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.159%-417%-993%-1,569%-2,145%20112012
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2011Operating margin-1,985.8%
2012Operating marginNot reported
2011Net margin-1,985.8%
2012Net marginNot reported
2011Free cash flow marginNot reported
2012Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.2M 2012
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.225.2K-591.3K-1.4M-2.2M-3.0M20112012
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2011Operating cash flow-2815514
2012Operating cash flow-1154126

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.2M 2012
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.92.3K-242.4K-577.1K-911.8K-1.2M20112012
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2011Free cash flowUnavailable
2012Free cash flow-1154126

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

391.6% 2012
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1,128%846%564%282%0%20112012
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2011Liabilities / assets1,044.3%
2012Liabilities / assets391.6%

Current assets to current liabilities

Current assets divided by current liabilities.

0.14× 2012
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.15×0.12×0.08×0.04×0.00×20112012
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2011Current assets / current liabilities0.09×
2012Current assets / current liabilities0.14×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2008 2008-01-14 – 2008-12-31
−USD 406,706
Exact value

Exact value: -406706 USD

2008-01-14 – 2008-12-31: -406706 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2009 2009-01-01 – 2009-12-31
−USD 306,190
Exact value

Exact value: -306190 USD

2009-01-01 – 2009-12-31: -306190 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2010 2010-01-01 – 2010-12-31
−USD 1.21 million
Exact value

Exact value: -1207561 USD

2010-01-01 – 2010-12-31: -1207561 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 538,549
Exact value

Exact value: -538549 USD

2010-01-01 – 2010-12-31: -538549 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable The mapped spending value is negative, so its direction is unclear.
Source
Unavailable

Capital expenditure has a negative mapped value; spending direction is unclear.

2011 2011-01-01 – 2011-12-31
−USD 4.44 million
Exact value

Exact value: -4440103 USD

2011-01-01 – 2011-12-31: -4440103 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 2.82 million
Exact value

Exact value: -2815514 USD

2011-01-01 – 2011-12-31: -2815514 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable The mapped spending value is negative, so its direction is unclear.
Source
Unavailable

Capital expenditure has a negative mapped value; spending direction is unclear.

2012 2012-01-01 – 2012-12-31
−USD 5.14 million
Exact value

Exact value: -5135618 USD

2012-01-01 – 2012-12-31: -5135618 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.15 million
Exact value

Exact value: -1154126 USD

2012-01-01 – 2012-12-31: -1154126 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2012-01-01 – 2012-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.15 million
Calculation and evidence

-1154126 − 0 USD

Exact free cash flow: -1154126 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2013 2013-01-01 – 2013-12-31
−USD 15.13 million
Exact value

Exact value: -15132000 USD

2013-01-01 – 2013-12-31: -15132000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.47 million
Exact value

Exact value: -3473000 USD

2013-01-01 – 2013-12-31: -3473000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2013-01-01 – 2013-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.47 million
Calculation and evidence

-3473000 − 0 USD

Exact free cash flow: -3473000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2014 2014-01-01 – 2014-12-31
−USD 27.28 million
Exact value

Exact value: -27277000 USD

2014-01-01 – 2014-12-31: -27277000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 11.33 million
Exact value

Exact value: -11331000 USD

2014-01-01 – 2014-12-31: -11331000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 181,000
Exact value

Exact value: 181000 USD

2014-01-01 – 2014-12-31: 181000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 11.51 million
Calculation and evidence

-11331000 − 181000 USD

Exact free cash flow: -11512000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2015 2015-01-01 – 2015-12-31
−USD 25.21 million
Exact value

Exact value: -25214000 USD

2015-01-01 – 2015-12-31: -25214000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 16.01 million
Exact value

Exact value: -16014000 USD

2015-01-01 – 2015-12-31: -16014000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 10,000
Exact value

Exact value: 10000 USD

2015-01-01 – 2015-12-31: 10000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 16.02 million
Calculation and evidence

-16014000 − 10000 USD

Exact free cash flow: -16024000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

51 filings · 1,310 latest values · 1,310 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001424812, 1424812, AMBS, AMBSE, edgar:1424812

Also known as AMARANTUS BIOSCIENCE, INC., Amarantus BioSciences, Inc., Amarantus Bioscience Holdings, Inc., Amarantus Biosciences, Inc., Jumpkicks, Inc.